Athenex Pharmaceutical Division, LLC. drugs
9 results
Bivalirudin (bivalirudin)
(bivalirudin)Athenex Pharmaceutical Division, LLC.
Usage: Bivalirudin RTU Injection is indicated as an anticoagulant for patients undergoing percutaneous coronary intervention (PCI), particularly those with heparin-induced thrombocytopenia (HIT) and HIT with thrombosis syndrome.
Bumetanide (bumetanide)
(bumetanide)Athenex Pharmaceutical Division, LLC.
Usage: Bumetanide injection is indicated for treating edema related to congestive heart failure, hepatic disease, renal disease, and nephrotic syndrome. It can be administered orally or via injection if oral use is not feasible. It is effective even in patients with allergies to furosemide, showing no cross-sensitivity.
Eptifibatide (eptifibatide)
(eptifibatide)Athenex Pharmaceutical Division, LLC.
Usage: Eptifibatide injection is indicated for reducing the rates of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and for decreasing the risk of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), including those receiving stents.
Furosemide (furosemide)
(furosemide)Athenex Pharmaceutical Division, LLC.
Usage: Furosemide is indicated for treating edema related to congestive heart failure, liver cirrhosis, and renal disease. It is also used adjunctively in acute pulmonary edema when rapid diuresis is needed, particularly via parenteral routes for patients unable to take oral medication.
Levothyroxine sodium (levothyroxine sodium anhydrous)
(levothyroxine sodium anhydrous)Athenex Pharmaceutical Division, LLC.
Usage: Levothyroxine Sodium for Injection is indicated for the treatment of myxedema coma. Caution is advised when switching from oral levothyroxine products, as relative bioavailability and accurate dosing conversion have not been established.
Palonosetron hydrochloride (palonosetron hydrochloride)
(palonosetron hydrochloride)Athenex Pharmaceutical Division, LLC.
Usage: Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting in adults undergoing moderately or highly emetogenic cancer chemotherapy and for treating postoperative nausea and vomiting. It is also approved for pediatric patients aged 1 month to under 17 years for chemotherapy-related nausea and vomiting prevention.
Thiotepa (thiotepa)
(thiotepa)Athenex Pharmaceutical Division, LLC.
Usage: Thiotepa for Injection is indicated for palliation of various neoplastic diseases, particularly effective in adenocarcinomas of the breast and ovary, controlling intracavitary effusions, and treating superficial papillary carcinoma of the urinary bladder. It has also shown effectiveness against some lymphomas, despite being largely replaced by other treatments.
Valproate sodium (valproate sodium)
(valproate sodium)Athenex Pharmaceutical Division, LLC.
Usage: Valproate Sodium Injection is indicated for intravenous use in epilepsy, specifically for complex partial seizures and simple/complex absence seizures, both as monotherapy and adjunctive therapy. It is not recommended for pregnant women or those of childbearing potential without alternative treatment failures due to potential fetal risks.
Zoledronic acid (zoledronic acid)
(zoledronic acid)Athenex Pharmaceutical Division, LLC.
Usage: Zoledronic Acid Injection is indicated for treating hypercalcemia of malignancy, characterized by corrected calcium levels ≥ 12 mg/dL. It is also used for patients with multiple myeloma and bone metastases from solid tumors alongside standard cancer therapies. Safety for other hypercalcemia causes is unestablished.